Literature DB >> 7219546

alpha-Lactalbumin is not a marker of human hormone-dependent breast cancer.

L Hall, R K Craig, M S Davies, D N Ralphs, P N Campbell.   

Abstract

It has been proposed that milk protein gene expression in human breast carcinomas may indicate a functional oestrogen receptor mechanism, and may therefore be diagnostic of tumours responsive to endocrine therapy. Unfortunately this has not been proved, largely because of inconsistencies in the immunoassay procedures used to identify milk proteins, in particular alpha-lactalbumin, in tissue extracts or serum. Alternative procedures include the identification of milk protein mRNA by cell-free protein synthesis, and the identification of milk protein RNA transcripts by hybridization to a sequence-specific probe. Here we describe experiments using alpha-lactalbumin cDNA probes, purified using recombinant plasmids, which demonstrate that although polyadenylated and non-polyadenylated alpha-lactalbumin transcripts are present in normal human mammary tissue during pregnancy and lactation, alpha-lactalbumin transcripts are not detectable in the human tumour tissues studied. These experiments do however show that a peptide, which shares antigenic determinants with human alpha-lactalbumin is present in some breast tumour tissues.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7219546     DOI: 10.1038/290602a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  6 in total

Review 1.  Translational regulation of milk protein synthesis at secretory activation.

Authors:  Robert E Rhoads; Ewa Grudzien-Nogalska
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-11-17       Impact factor: 2.673

2.  Prophylactic cancer vaccination by targeting functional non-self.

Authors:  Vincent K Tuohy; Ritika Jaini
Journal:  Ann Med       Date:  2011-06-09       Impact factor: 4.709

3.  An autoimmune-mediated strategy for prophylactic breast cancer vaccination.

Authors:  Ritika Jaini; Pavani Kesaraju; Justin M Johnson; Cengiz Z Altuntas; Daniel Jane-Wit; Vincent K Tuohy
Journal:  Nat Med       Date:  2010-05-30       Impact factor: 53.440

4.  A prophylactic vaccine for breast cancer?

Authors:  Christine J Watson; Barry A Gusterson
Journal:  Breast Cancer Res       Date:  2010-08-31       Impact factor: 6.466

5.  Immunohistochemical markers in the identification of metastatic breast cancer.

Authors:  P C de Almeida; C B Pestana
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 6.  The detection and evaluation of human tumor metastases.

Authors:  D J Laurence; A M Neville
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.